| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Mar 4, 2025 | NovoCure Ltd | Chief Innovation Officer | Sell | 52.5 | -268 | -0.16% | ✗ | $5.1K |
| Feb 28, 2025 | Mar 3, 2025 | NovoCure Ltd | Chief Innovation Officer | Sell | 42.5 | -4,637 | -2.71% | ✗ | $86.9K |
| Feb 28, 2025 | Mar 3, 2025 | NovoCure Ltd | Chief Innovation Officer | Sell | 22.5 | -4,637 | -2.71% | ✗ | $86.9K |
| Jan 5, 2023 | Jan 9, 2023 | NovoCure Ltd | Chief Science Officer | Sell | 20.0 | -8,143 | -4.28% | ✗ | $945.8K |
| May 10, 2021 | May 12, 2021 | NovoCure Ltd | Chief Science Officer | Sell | 17.5 | -5,650 | -15.14% | ✗ | $1.1M |
| Mar 23, 2021 | Apr 9, 2021 | NovoCure Ltd | Chief Science Officer | Sell | 20.0 | -2,835 | -7.81% | ✗ | $396.9K |
| Mar 23, 2021 | Mar 25, 2021 | NovoCure Ltd | Chief Science Officer | Sell | 20.0 | -3,892 | -9.68% | ✗ | $544.9K |
| Feb 22, 2021 | Feb 24, 2021 | NovoCure Ltd | Chief Science Officer | Sell | 17.5 | -6,500 | -19.06% | ✗ | $1.1M |
| Sep 25, 2020 | Sep 28, 2020 | NovoCure Ltd | Chief Science Officer | Sell | 17.5 | -15,250 | -21.65% | ✗ | $1.6M |